Thomson buys major drug information service.

Newsletter on Newsletters, The, August, 2002

The Thomson Corporation recently acquired the privately held, U.K.-based Current Drugs Ltd., a global leader in the delivery of integrated competitor intelligence services to the research solutions market serving the pharmaceutical and biotechnology industry.

Current Drugs provides databases, systems and services such as the Investigational Drugs database, the premier service for scientists and business executives involved in drug research and development.

The van Tulleken Company represented Current Drugs Ltd. in the transaction, the financial terms of which were not disclosed.

Current Drugs will become part of the Scientific & Healthcare operating group within Thomson and will continue to be run by its current business management group led...

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement
Click Here